These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 25975233
1. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer. Wang J, Zhang X, Wang L, Dong Z, Du L, Yang Y, Guo Y, Wang C. J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233 [Abstract] [Full Text] [Related]
2. Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer. Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS, Song PH, Choi YH, Kim IY, Moon SK, Kim WJ. Int J Oncol; 2012 Nov; 41(5):1871-8. PubMed ID: 22961325 [Abstract] [Full Text] [Related]
5. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer. Baumgart S, Meschkat P, Edelmann P, Heinzelmann J, Pryalukhin A, Bohle R, Heinzelbecker J, Stöckle M, Junker K. J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489 [Abstract] [Full Text] [Related]
6. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. Shimizu T, Suzuki H, Nojima M, Kitamura H, Yamamoto E, Maruyama R, Ashida M, Hatahira T, Kai M, Masumori N, Tokino T, Imai K, Tsukamoto T, Toyota M. Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812 [Abstract] [Full Text] [Related]
8. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection. Pospisilova S, Pazourkova E, Horinek A, Brisuda A, Svobodova I, Soukup V, Hrbacek J, Capoun O, Hanus T, Mares J, Korabecna M, Babjuk M. Neoplasma; 2016 Jun; 63(5):799-808. PubMed ID: 27468885 [Abstract] [Full Text] [Related]
10. A urinary microRNA (miR) signature for diagnosis of bladder cancer. Hofbauer SL, de Martino M, Lucca I, Haitel A, Susani M, Shariat SF, Klatte T. Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728 [Abstract] [Full Text] [Related]
12. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer. Tölle A, Jung M, Rabenhorst S, Kilic E, Jung K, Weikert S. Oncol Rep; 2013 Oct; 30(4):1949-56. PubMed ID: 23877086 [Abstract] [Full Text] [Related]
16. Is urinary soluble Fas an independent predictor of non-muscle-invasive bladder cancer? A prospective chart study. Yang H, Li H, Wang Z, Gao J, Guo Y. Urol Int; 2013 Oct; 91(4):456-61. PubMed ID: 23948854 [Abstract] [Full Text] [Related]
18. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC. Ding W, Gou Y, Sun C, Xia G, Wang H, Chen Z, Tan J, Xu K, Qiang D. Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660 [Abstract] [Full Text] [Related]
19. Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models. Mengual L, Ribal MJ, Lozano JJ, Ingelmo-Torres M, Burset M, Fernández PL, Alcaraz A. J Urol; 2014 Jan; 191(1):261-9. PubMed ID: 23831312 [Abstract] [Full Text] [Related]